GE HealthCare Technologies (GEHC) Capital Expenditures (2022 - 2026)

GE HealthCare Technologies has reported Capital Expenditures for 5 years, with the latest figure at $86.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 43.42% year-over-year to $86.0 million; the trailing twelve-month figure through Mar 2026 stood at $416.0 million (up 177.33% YoY), and the FY2025 full-year result was $482.0 million, up 237.06% from the prior year.
• Capital Expenditures for Q1 2026 stood at $86.0 million, down from $134.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $258.0 million in Q3 2025, with the low at -$156.0 million in Q4 2024.
• Historically, Capital Expenditures has averaged $82.8 million across 5 years, with a median of $86.0 million in 2026.
• Annual changes were most pronounced in 2024 — Capital Expenditures slumped 265.96% — and 2025, when it surged 186.67%.
• GE HealthCare Technologies' Capital Expenditures stood at $77.0 million in 2022, then rose by 22.08% to $94.0 million in 2023, then tumbled by 265.96% to -$156.0 million in 2024, then soared by 185.9% to $134.0 million in 2025, then slumped by 35.82% to $86.0 million in 2026.
• The last three Capital Expenditures figures came in at $86.0 million (Q1 2026), $134.0 million (Q4 2025), and $258.0 million (Q3 2025), per Business Quant data.